fullerene c60 has been researched along with Dermatitis, Allergic Contact in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezerra, SF; Brito, HRG; Cintra, ER; da Silva, ACG; de Ávila, RI; Dos Santos Rodrigues, B; Lima, EM; Valadares, MC; Veloso, DFMC | 1 |
1 other study(ies) available for fullerene c60 and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
Application of the adverse outcome pathway framework for investigating skin sensitization potential of nanomaterials using new approach methods.
Topics: Adverse Outcome Pathways; B7-2 Antigen; Biomarkers; Cytokines; Dermatitis, Allergic Contact; Fullerenes; HaCaT Cells; Humans; Immunomodulation; Keratinocytes; Nanotubes, Carbon; Titanium; U937 Cells | 2021 |